-

COVID-19 Vaccine Developments Subscription: Therapeutics Experiments and Diagnostics/Devices Advances - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle" report has been added to ResearchAndMarkets.com's offering.

The COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle includes:

  • Subscription to 6 Dailies
  • Subscription to 6 Weekly Summary Reports
  • Subscription to 6 Monthly Synthesis Reports

Choices available to choose from:

Daily: 27 Daily reports available

To choose one Daily report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Weekly: 15 Weekly summary reports available

To choose one Weekly summary report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Monthly: 22 Monthly synthesis reports available

To choose one Monthly report from the available sub-categories within each of the three categories

Key Topics Covered:

Coverage - Daily Reports:

  • Daily report offer at five different time zones, daily updates for 20+ global news each related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances, comprehensively compiled and curated from global as well as regional and local news media.
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 key regions - Americas, Asia, Emerging Markets, and Europe
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 healthcare sub-industries - Biotechnology, Healthcare Services, Medical Devices, and Pharmaceuticals
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 market capitalization levels - LargeCap Companies, Small-MidCap Companies, Privately-Owned Companies, and Non-Profit Organizations

Coverage - Weekly Summary Reports:

  • A weekly presentation of all the recent crucial development related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for American, Asian, Emerging Market, and European companies, research institutes, academia, and healthcare organizations rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for Biotechnology, Healthcare Services, Medical Devices, and Pharmaceutical companies worldwide rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for LargeCap, Small-MidCap, and Privately-owned companies, and Non-Profit organizations worldwide rounded up and summarized succinctly to present a complete overview of the current happenings

Coverage - Monthly Synthesis Reports:

  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Vaccine Development such as Clinical/Human Trials, Global Grants/Funding, Licensing, Manufacturing/Purchasing/Selling, Regulatory Approvals, and Research/Studies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Therapeutics Experiments such as Clinical Trials, Global Grants/Funding, Existing Medicines Research, Licensing, Manufacturing/Production/Selling, Regulatory Approvals, Research/Studies, and Treatment/Therapies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Diagnostics/Devices Advances such as Global Grants/Funding, Licensing, Manufacturing/Development/Production, Regulatory Approvals, Research/Studies, Technology Updates, Testing, and Testing Kits/Facilities/Sites

For more information about this report visit https://www.researchandmarkets.com/r/u4nian

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom